These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8030754)

  • 21. Saccharides of senile plaques and neurofibrillary tangles in Alzheimer's disease.
    Mann DM; Bonshek RE; Marcyniuk B; Stoddart RW; Torgerson E
    Neurosci Lett; 1988 Feb; 85(2):277-82. PubMed ID: 3374842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification.
    Takeda A; Smith MA; Avilá J; Nunomura A; Siedlak SL; Zhu X; Perry G; Sayre LM
    J Neurochem; 2000 Sep; 75(3):1234-41. PubMed ID: 10936206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.
    Goedert M
    Arzneimittelforschung; 1995 Mar; 45(3A):403-9. PubMed ID: 7763334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies to Alzheimer neurofibrillary tangles. 2. Demonstration of a common antigenic determinant between ANT and neurofibrillary degeneration in progressive supranuclear palsy.
    Dickson DW; Kress Y; Crowe A; Yen SH
    Am J Pathol; 1985 Aug; 120(2):292-303. PubMed ID: 2411143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofibrillary pathology in the human paraventricular and supraoptic nuclei.
    Schultz C; Ghebremedhin E; Braak H; Braak E
    Acta Neuropathol; 1997 Jul; 94(1):99-102. PubMed ID: 9224538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease.
    Zhu X; Ogawa O; Wang Y; Perry G; Smith MA
    J Neurochem; 2003 Apr; 85(1):87-93. PubMed ID: 12641730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunocytochemical comparison of neurofibrillary tangles in senile dementia of Alzheimer type, progressive supranuclear palsy, and postencephalitic parkinsonism.
    Yen SH; Horoupian DS; Terry RD
    Ann Neurol; 1983 Feb; 13(2):172-5. PubMed ID: 6187274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibodies against the human metalloprotease EC 3.4.24.15 label neurofibrillary tangles in Alzheimer's disease brain.
    Conn KJ; Pietropaolo M; Ju ST; Abraham CR
    J Neurochem; 1996 May; 66(5):2011-8. PubMed ID: 8780030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes.
    Braak H; Braak E
    J Neuropathol Exp Neurol; 1990 May; 49(3):215-24. PubMed ID: 1692337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment.
    Schipper HM; Bennett DA; Liberman A; Bienias JL; Schneider JA; Kelly J; Arvanitakis Z
    Neurobiol Aging; 2006 Feb; 27(2):252-61. PubMed ID: 16399210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles.
    Sugata H; Matsuo K; Nakagawa T; Takahashi M; Mukai H; Ono Y; Maeda K; Akiyama H; Kawamata T
    Neurosci Lett; 2009 Aug; 459(2):96-9. PubMed ID: 19414059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
    Walton JR
    J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
    Pei JJ; Sjögren M; Winblad B
    Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy?
    Masliah E; Hansen LA; Quijada S; DeTeresa R; Alford M; Kauss J; Terry R
    Ann Neurol; 1991 Apr; 29(4):389-96. PubMed ID: 1929210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to presenilin proteins detect neurofibrillary tangles in Alzheimer's disease.
    Murphy GM; Forno LS; Ellis WG; Nochlin D; Levy-Lahad E; Poorkaj P; Bird TD; Jiang Z; Cordell B
    Am J Pathol; 1996 Dec; 149(6):1839-46. PubMed ID: 8952521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neurofibrillary changes and phosphorylated tau of Alzheimer's disease].
    Takeda M; Kudo T; Taniguchi N; Nishimura T
    Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):169-72. PubMed ID: 8648891
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of protein kinase B in Alzheimer's neurofibrillary pathology.
    Pei JJ; Khatoon S; An WL; Nordlinder M; Tanaka T; Braak H; Tsujio I; Takeda M; Alafuzoff I; Winblad B; Cowburn RF; Grundke-Iqbal I; Iqbal K
    Acta Neuropathol; 2003 Apr; 105(4):381-92. PubMed ID: 12624792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C; Colle MA; Delatour B; Hauw JJ
    Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.